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Improvements in Pain, Well-being,
Arterial Pressure, and Lower Limb Volume
Following Andullation Therapy in Healthy
and Unhealthy Humans
Alba Parras-Molto´1 and Juan Ribas-Serna1
Abstract
Our aim was to test the effects of Andullation therapy on pain threshold, pain perception, feeling of well-being, arterial pressure,
and leg volume in healthy and unhealthy patients. We used a multidirectional vibration (frequency range: 5–40 Hz; peak-to-peak
amplitude: 2–8 mm; acceleration: 0.4–2 m/s2) in an undulatory way through the surface of the body when the patient was in
contact with a mattress (“andullation”). The vibes traveled from the heel to the head in a random fashion while the participants
(N¼ 50) were lying on the mattress. We measured the pain threshold using an algometer; pain perception and well-being through
a visual analog scale (VAS); arterial pressure with an electronic sphygmomanometer; and leg volume with Kuhnke’s technique.
Measurements were made just before the first andullation session and after the fifth andullation session. Every participant received
andullation sessions of 30 min a day for 5 consecutive days. The patients’ pain threshold significantly (P < .001) increased by 34.48%
and 25.79% in the lumbar and trapezius zones, respectively, after 5 sessions of therapy. The subjective perception of pain
decreased by 52.3% and the feeling of well-being increased by 45.1%. The systolic and diastolic pressures significantly (P < .001)
decreased by 6.44 and 4.68 mmHg on average, respectively. Leg volume significantly decreased (P < .01) by 64.39 mL after the fifth
andullation session. Despite not including a control group in our study, the andullation intervention showed an improvement in
pain, well-being, arterial pressure, and lower limb volume in the studied population.
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Introduction
The effects of vibration on the human body have been widely
studied as both a source of injuries and as a way to treat dif-
ferent diseases. The potential risk of using vibration has been
well established in the International Standards Organization
(ISO, 5349-1) and in British Standard (BS6841).1-4 On the
other hand, the use of vibrations to improve the effects of
physical training and to ameliorate the clinical signs of differ-
ent pathologies has been extensively reported.5-10 However,
most interventions have used the whole-body vibration (WBV)
technique in a passive mode as well as combined with exer-
tion.11-18 Whole-body vibration is normally applied through a
platform that vibrates at a fixed frequency and amplitude
selected by the user. Normally, participants under experimen-
tation stand up, lean, or sit on the vibrating platform for a short
period of time (<5 min).
The acute effects of WBV on pain level, flexibility, and
cardiovascular responses have been explored using vibration
frequencies of 5–14 Hz and displacements of 2.5–7.5 mm. The
results from these studies showed significant improvements in
pain level, flexibility, gait speed, sit-to-stand test, and handgrip
strength but have failed to show any change in blood
pressure.19,20
Whole-body vibration has been postulated as being able to
improve the quality of life of patients with metabolic syndrome
and severe chronic obstructive pulmonary disease, along with
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being able to improve blood flow in patients with type 2 dia-
betes and muscle flexibility and pain in fibromyalgia and neu-
rological patients.16,21 Bidonde et al.21 extensively reviewed
the effect of WBV training for fibromyalgia and found several
outcomes in fibromyalgia patients (based on the findings of one
study) that showed improvements of 39%, 46%, and 36% in
pain intensity, fatigue, and stiffness, respectively, after WBV
plus mixed exercise, what met the 15% threshold for clinical
relevance but at a lower level of evidence.
Active or passive WBV combined with moist heat has been
shown to elevate skin blood flow by 450% when using a vibra-
tion frequency of 50 Hz and a mechanical displacement of 5–6
mm during 10 bouts of 60 seconds.16 However, the combina-
tion of WBV exercise (26 Hz, 4 mm amplitude) with blood
restriction during 10 sets of 1 min on and 1 min off duty cycles
produced an increase in electromyogram amplitude and eleva-
tion of the lactate and growth hormone responses.18
Local vibration has also been applied to recovery from exer-
cise. However, the results evidenced no benefit during the
recovery, probably because of the weak mechanical action of
the vibrations.17
Currently, little literature exists on the application of andul-
lation on human patients. Andullation is a multidirectional
(3 axis oscillations) WBV technique that is delivered in a hor-
izontal position using a massage mattress (see Methods sec-
tion). It is possible that these kinds of vibrations when delivered
in an undulatory mode along the body’s surface may stimulate
mechanical receptors on the skin and in the subdermal tissue.
However, currently, only 2 articles using andullation appear in
databases such as PubMed, Scopus, or Medical Library (a few
articles have been published in journals or local publications
not included in the Journal Citation Report). One article
focused on human patients undergoing in vitro fertilization.22
The other article showed the effects of andullation on the blood
circulation of laboratory animals.23
In this article, we present for the first time data on the
physiological effects of andullation applied to humans. The
aim of our work is to ascertain the effects of andullation on
objective and subjective pain indicators, on a patient’s sensa-
tion of well-being, on arterial pressure, and on lower limb
volume.
Methods
Participants
Seventy human participants were recruited among the student
and staff population of the Faculties of Medicine and the Phy-
siotherapy (University of Seville). Twenty participants dropped
out of the study because they did not fulfill the experimental
conditions; specifically, 14 of 20 failed to attend one or more of
the 5 sessions for the andullation intervention. The other 5
participants succumbed to several illnesses during the experi-
mental period and rejected the intervention, and one participant
declined to participate. Finally, 50 participants were selected
for the andullation experiments. The participants were between
18 and 68 years old. The participants’ biometric characteristics
are shown in Table 1. The following inclusion criteria were
established for the current study: healthy participants and
unhealthy participants (with mild chronic arthropathies and/
or fibromyalgia but not to the point of curtailing their normal
activities). The exclusion criteria were as follows: participants
with severe cardiac disease, participants with surgical prosthe-
sis who were less than 6 months away from implantation, par-
ticipants with severe retinopathies, and participants with
circulatory vertebra-basilar insufficiency.
We used the checklist (version 1.0) of the TREND (trans-
parent reporting of evaluations with nonrandomized designs)
statement24 to report the steps of the intervention applied in this
study. A flow diagram of the intervention is shown in Figure 1.
The dependent variables (pain threshold, pain perception, well-
being perception, arterial pressure, and lower limb volume)
were measured before and after the andullation sessions.
All participants (N ¼ 50) were fully informed about the
andullation device and the entire procedure. Finally, all of the
participants voluntarily signed a written consent. The partici-
pants were also informed about their possibility to withdraw
Table 1. Biometry of the Experimental Participants.
Anthropometric Measures Mean (SD) (range)
Age, years 45.8 (14.3) (18-68)
Height, cm 164.5 (10.04) (147-203)
Weight (before andullation), kg 73.64 (17.16) (46.5-138.1)
Figure 1. Flow diagram of the clinical intervention.
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from the study at any time. The participants agreed to partici-
pate for 5 days for 1 h/day. The experiments were carried out at
the same place (clinical room) and within the same environ-
ment (22C and 75% humidity). The experimental condition
and the protocol used in this study were approved by the local
ethics committee (Comite´ E´tico de los Hospitales Universitar-
ios Virgen del Rocı´o y Virgen Macarena de la Junta de Anda-
lucı´a, code: 1740-N-17 Spain), following the 2003 Helsinki
Declaration.
Procedure
Data on the effects of andullation therapy were collected from
April to November of 2018. A medical anamnesis was com-
pleted for every subject before the andullation intervention.
The anthropometric characteristics of the participants were
measured by means of a stadiometer (50–260 cm, 1 mm accu-
racy; SECA 206, Spain) and a scale (0–250 kg, 50 g accuracy)
(SECA, Spain). We used a visual analog scale (VAS) for pain
and well-being perception, which was presented before and
after the andullation therapy. The patient’s well-being percep-
tion included how he or she felt about his or her mental tension,
moodiness, relaxing condition, and sleep quality. The scale for
pain perception is a 100-mm line joining both the “maximal
pain” end to the “no pain” end. Therefore, the participants
marked their perceptions of pain over the scale without having
to use numbers. After doing this, a researcher read the actual
number on the numbered reverse of the scale. The scale for
well-being perception was a 100-mm line limited by “no-well-
being at all” and “full well-being,” and the scores were
obtained similarly as for the pain perception scale.
We used an algometer (Dolorimeter, Rhabmedic, Spain;
range from 0 to 10 kg/cm2; accuracy: 0.1 kg/cm2) to obtain
an objective measurement of the pressure-induced pain on the
skin surface over the trapezius muscle (3 cm cranial to the
scapular spine and in the middle point between the posterior
apophysis of C7 and the lateral limit of the acromion) and over
the lumbar muscle (5 cm lateral to the posterior apophysis of
L2). The algometer consists of a manometer connected to a
metallic rod that ends in a 10-mm circle. Once the end of the
rod was placed on the skin, the pressure was manually
increased until the participants felt pain. The pressure pain
threshold was defined as the minimal pressure (kg/cm2) that
would produce pain.25-27
The andullation device (Home Health Product; medical
device [andumedic] certificated as Class IIa by Health Spanish
Authorities) consists of a mattress that includes 70 motors to
produce vibrations of different amplitudes (ranging from 2 to 8
mm peak to peak), accelerations (0.4–2 m/s2), and frequencies
(ranging from 5 to 40 Hz). We chose a frequency of 15 Hz,
amplitude of 7 mm, and acceleration of 1 m/s2 as the para-
meters for the andullation intervention. The activation and
amplitude of the vibrations were computer controlled and
sequentially activated to produce a vibratory wave through the
whole body of the subject, who stayed in a decubitus supine
position on the mattress. The vibrations traveled from the heel
to the head or vice versa. We also measured a portion of the
volume (more than 70% of the whole volume) of the thigh and
leg using Kuhnke’stechnique.28 In short, we measured 5 cir-
cumferences separated by 4 cm along the thigh and another
5 circumferences along the leg. The volume of every 4-cm long
cylinder was calculated and added to the results following
Kuhnke’s corrections, as expressed in the following formula:
V ¼ 1
p
S
n
i¼1
ðUiÞ2  1
2
ðUiÞ2 þ ðUnÞ2
 
where V is the volume of the thigh of the leg, Sni¼1ðUiÞ2 is the
sum of the squares of all the observations at a 4 cm distance,
and 12 ðUiÞ2 þ ðUnÞ2 is a correction for the first and last
measurement.
The time course of the procedure was the following (Figure
2): (a) after medical anamnesis, an anthropometry was per-
formed; (b) both subjective and objective evaluations of the
participant’s pain threshold was carried out using the algometer
and the VAS described above; (c) the participants were placed
in decubitus supine position on the andullation device and did
not move for the 15-min session; at the end of this period, the
arterial pressure (Omron sphygmomanometer device with an
arm cuff, Oregon Inc., USA) and thigh and leg volumes were
measured. Every measurement was repeated twice for the same
researcher, and the average value was incorporated into the
database; (e) then, the participants received a 30-min andulla-
tion session a day for 5 days; (f) after the fifth andullation
session, the participants stayed for a 15-min period on the
mattress. During the last 5 min of this period, arterial pressure
and thigh and leg volume were measured again. Finally, pain
level and well-being perception were again evaluated.
Statistics
We used the standardized differences of the mean to predeter-
mine an acceptable size of the sample. Using the NQuery soft-
ware, version 7.0, we entered a mean difference equal to or
higher than 25% (two-unit variability), a .05 of significance
level (a), and a standard deviation (s) of 4.232, resulting in a
sample size equal to 49 paired for a 90% of statistical power. A
normality test was conducted to the differences in the mean
values of selected variables before and after the andullation
therapy. When the data belonged to a normally distributed
population, a Student t test for paired samples was used, and
the significance was established as P < .05. These data derived
from a non-normal distributed population were analyzed with
the Wilcoxon test at significance of P < .05. In every case, a
confidence interval of 95% was used. We also calculated
Cohen’s d (mean difference/standard deviation) for the size
of the effect produced by the andullation intervention. We
estimated the size of the effect considering <0.2 as low, <0.5
as medium, and <0.8 as large. All the statistical calculations
and data plots were carried out using a professional spreadsheet
(OriginPro (2015), OriginLab corp. Northampton, MA, USA),
NQuery, version 7.0 (StatSols, 2019), and SPSS (IBM SPSS
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Statistics for Windows, Version 25.0. IBM Corp., Armonk,
NY, USA) software.
Results
We conducted a noninvasive intervention with a sample of 50
healthy and unhealthy participants using a waving vibes device
(AndullationO`). The participants were laid in a horizontal posi-
tion during all the andullation sessions. We obtained significant
differences in the mean values (N¼ 50) for pain threshold, pain
perception, well-being perception, and lower limb volume
before and after the intervention.
Pain
The pain threshold for the trapezius zone increased by 25.79%
after the andullation intervention. The pain threshold (N ¼ 50)
over the skin on the trapezius muscle before the first andulla-
tion session was 3.76 (1.79) kg/cm2 (mean [SD]) and 4.73
(2.14) kg/cm2 (P < .01) after the andullation on the fifth day;
the confidence interval (CI) (95%) increased from 0.51665 to
1.38735. The pain threshold in the lumbar zone increased by
34.48% after the andullation intervention. The mean value
(N ¼ 50) of the pain threshold in the lumbar zone immediately
before the first intervention with andullation was 4.152 (1.77)
kg/cm2and went up to 5.584 (2.19) kg/cm2 (P < .001) after the
last andullation session on the fifth day (Figure 3), with a CI
(95%) going from 0.99888 to 1.86512. The largest pain thresh-
old increase (1,432 kg/cm2) was measured in the lumbar zone
between the preandullation session on the first day and the
postandullation session on the fifth day. The effect size of the
pain threshold for the lumbar and trapezius zones after the fifth
andullation session was 0.807 (large) and 0.528 (medium),
respectively. The full data are presented in Table 2.
The mean value of the pain perception significantly (P <
.001) decreased by 52.3% from 2.92 (2.66) before the first
andullation session to 1.09 (1.85) after the fifth andullation
session, as shown in Figure 4.
Using the same VAS as described in the Methods section,
the well-being of the participants improved after the interven-
tion. The well-being score changed significantly (P < .001)
from 5.88 (2.24) to 8.46 (1.88), a 45.1% increase, as shown in
Figure 5.
Arterial Pressure
Both the systolic and diastolic pressures changed after 5 andul-
lation sessions. The systolic pressure significantly (P < .001)
Figure 2. Measurements carried out before and after the andullation intervention.
Figure 3. Changes in the pain threshold induced by andullation. The columns represent the mean and standard deviation of the pain thresholds
before the first andullation session (Day 1 PRE); Day 5 POST are the data measured after the last andullation session on the fifth day of therapy.
n ¼ number of subjects; * ¼ statistical significance (P  .05).
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varied by 5.21%, going from 123.6 (16.9) mm Hg at the first
andullation session to 117.16 (15.1) mm Hg after the fifth
session of andullation, with lower and upper CIs (95%) of
4.005 and 8.234 and 3.709 and 9.170, respectively (Figure 6).
Diastolic pressure also significantly (P < .001) decreased by
6.05% after the 5 andullation sessions. The diastolic pressure
mean values before the andullation session were 77.34 (9.5)
mm Hg and were 72.66 (8.4) mm Hg after the fifth andullation
session. The lower and upper limits of the confidence intervals
were 1.707 and 4.492 for the values on the first day before the
andullation intervention and 3.042 and 6.31 after the last andul-
lation session (Figure 6).
Lower Limb Volume
Leg volume significantly (P < .01) decreased on average by
64.39 mL (20.98) after the 5 andullation sessions (Figure 7).
The confidence intervals were 11.35 (lower limits) and 74.37
(upper limits). However, the thigh mean volume was not sig-
nificantly (P < .16) lower (134.65 mL) after the 5 andullation
sessions. The thigh mean (SD) volume before andullation was
4191.85 (1376.36) and dropped to 4057.2 (1290.92) after the
fifth day of the andullation therapy (Figure 7).
Discussion
The main objective of this work is to clarify the possible effects
of a novel vibratory therapy (Andullation) on pain, well-being,
arterial pressure, and lower limb volume in healthy and
unhealthy patients. For this first approach, we did not recruit
a control group to avoid possible ethical conflicts with
Figure 4. Changes in the mean values of the VAS score before the
first intervention and after the fifth intervention with the andullation
device. *Statistical significance (P < .01).
Figure 5. Changes in well-being of the participants (N ¼ 50) in the
study. *Statistical significance (P < .001).
Table 2. Pain Threshold (Pthres) Changes Before and After the Intervention with Andullation.a
Muscle Zone Pthres (Mean), (kg/cm2) SD SEM r Lower CI 95% Upper CI 95% Effect Size
LZ POST day 5 5.584 2.19437 0.31033 2.36  106 0.99888 1.86512 0.80795
LZ PRE day 1 4.152 1.77238 0.25065
TRP POST day 5 4.732 2.14071 0.30274 5.94  105 0.51665 1.38735 0.52892
TRP PRE day 1 3.78 1.79989 0.25454
Abbreviations: CI: confidence interval; LZ: lumbar zone; SD: standard deviation; SEM: standard error of the mean; TRP: trapezius zone.
aEffect size: as described in statistic. PRE and POST is related to before and after the andullation intervention.
Figure 6. Changes in the systolic and diastolic pressures before the
first and after the fifth andullation session. The data plot is truncated
for a better visualization of the change. Day 1 PRE: data obtained
before the first intervention on the first day. Day 5 POST: data mea-
sured after the fifth andullation session. *P  .001. N ¼ 50.
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unhealthy participants not receiving the treatment, hence
implying a limit to the generalization of the possible results.
On the other hand, the design of the study as a pairwise analysis
allowed us to compare paired samples before and after the
intervention.
Pain Threshold
We chose 2 different body areas covering the trapezius and
lumbar muscles to test the pain threshold of the participants.
We chose the area over the trapezius muscle, because it is one
of the most sensitive to psychological and physiological
stress.29,30 On the other hand, the lumbar zone is probably the
most commonly tested area in painful pathologies of the lower
back.29,31-33 We measured the pain threshold using an alg-
ometer device, because it is the most frequently used device
by clinical therapists when compared with controlled heating
source devices.
It has been shown that vibrations are related to a decrease in
pain sensitiveness.31 The mechanical characteristics of the
andullation device allowed the stimulation of the skin and the
muscular and subcutaneous tissues with a new pattern of vibes.
According to the gate control theory, the stronger the activation
of mechanical peripheral receptors are, the weaker the nocicep-
tive signal entering the brain will be.34,35 This effect might be
accounted for by decreasing the magnitude of the nociceptive
input to the projection neurons in the dorsal root of spinal cord,
which could underlies the increase in the pain threshold
observed in our study. Another possible effect could be that
vibratory stimulation enables the facilitation of the synapses of
the peripheral receptor fibers because of the inhibitory inter-
neurons in the dorsal root of the spinal cord, but this remains to
be clarified. On the other hand, the magnitude of the change in
the pain threshold seems to be large because the andullation
intervention was only applied for 30 min a day for 5 days. The
possible effects of longer andullation sessions on pain thresh-
old are out of the scope of the current study. Using shorter
interventions, Sa´-Caputo et al.20 found a significant (P¼.031)
reduction in the pain level of a group of 29 patients with meta-
bolic syndrome after they had been submitted to 3 bouts (1 min
each) of WBV exercise. Our results also showed a significant
reduction in the pain level after the intervention when using a
visual analog pain scale. Unlike Sa´-Caputo et al., we measured
the pain level in a more objective way using an algometer and
obtained a significant increase in the pain threshold levels of
the patients.
Similarly, when using a vertical vibrational platform, Alev
et al. reported a reduction in VAS for pain although they did not
discuss any mechanism by which the vibration can reduce pain
or improve the body’s tonic reflexes. The amplitude of the
vibration and the frequency are the key points in this procedure,
because they determine the load imposed by the vibration in the
neuromuscular system during training.36 However, WBV dif-
fers remarkably from an andullation device. Whole-body vibra-
tion uses the same vibratory characteristics to the part of the
body on the platform, whereas andullation uses a wave of
multidirectional vibrations over the whole surface of the patient
who is reposed on the mattress.
The use of vertical WBV together with exercise for the
treatment of sports injuries37-39 can produce positive results for
the pain VAS. Evidence for WBV is not clear when it comes to
reducing pain in patients with diseases such as fibromyal-
gia.11,21 Moretti et al.21,40 concluded that it was not possible
to evaluate the magnitude of the effect of WBV treatment and
stated that the results are based on evidence of very low quality
and were inconclusive regarding pain. There is no evidence to
demonstrate the use of WBV therapy throughout the body for
the treatment of women with fibromyalgia, because there are
no clinically relevant effects in reducing pain, controlling fati-
gue, and improving quality of life.21,40 Collado-Mateo et al.41
compiled 8 articles on WBV, of which only in one of them was
pain specifically assessed and showed an improvement com-
pared with the control group. However, no objective measure-
ment of pain level was used in these studies, whereas in our
study, the pain, which was produced by pressure applied over 2
Figure 7. Changes in leg and thigh volume of participants (N ¼ 50). Values are expressed as the mean and standard deviation. Day 1 PRE:
measurements made before the andullation session. Day 5 POST: measurements made after the fifth session of andullation therapy. *Statistical
significance for P < .05. (N ¼ 50 for leg and thigh volumes).
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body areas, was quantified by an algometer. Furthermore, we
obtained an effect size of 0.8 (considered large) for the changes
produced by andullation therapy on the pain threshold in the
lumbar zone.
The well-being scores of most of the participants in our
study improved after the andullation therapy. Because the
experimenter did not intervene in the decision of the partici-
pants and because the participants were not informed of any
expectancy of the treatment, the changes in the score values
came from the internal feelings of the participants.
Arterial Pressure
The systolic and diastolic arterial pressure dropped by 6.44 mm
Hg and 4.68 mm Hg, respectively, on average. These changes
could be attributed to the change in body position from stand-
ing up to lying on the mattress. Nevertheless, to allow for
cardiovascular adaptation, we waited for 15 min after the
change in body position to measure arterial pressure before the
first andullation session. Arterial pressure was measured again
after the fifth intervention. Therefore, we ensured that changes
in arterial pressure were closely related to the vibration therapy.
On the other hand, the magnitude of the changes was small, as
expected when taking into account the daily 30-min period of
the vibratory stimulation; even so, these changes were statisti-
cally significant. Other authors have reported changes in arter-
ial pressure using vibratory devices (WBV) associated with
exertion, which is known to affect arterial pressure.7,42,43 How-
ever, Sa´-Caputo et al.19,20 did not find any change in the arterial
pressure of participants with metabolic syndrome after 3 bouts
of 1 min WBV stimulation. Possibly, the physiological char-
acteristics of the selected patients with metabolic syndrome,
the small surface (only feet on the vibratory platform) receiving
the vibration, and the short time (1 min 3) of the vibration
stimulation influenced those results.
In our study, the participants did not perform any exer-
cise when on the mattress. The arterial pressure of the par-
ticipants was measured using a conventional electronic
sphygmomanometer. Nevertheless, to reduce the variability
in the final reported values of this device, we repeat twice
the measurement of the arterial pressure and the mean of
these 2 values used for comparison. The electronic blood
pressure measurer also avoided a subjective appraisal of the
Korokov’s sounds that an experimenter can hear in mechan-
ical sphygmomanometers.
The changes in lower extremity volume could be ascribed to
the lying position. Nevertheless, we waited for 15 min, keeping
the patient in the same position as in the andullation session
before measuring the leg volume, so fluid drainage from the leg
was possibly stabilized before the andullation session. The fact
that the change in thigh volume after the andullation sessions
was not significant (P < .16) might be explained by the large
volume of this area, which would require a larger difference of
volume or a larger population for a small increment of volume
to become significant. The small change in thigh volume might
also be because of drainage from the leg to the thigh.
Although other techniques, such as disc model or water
displacement volumetry for limb volume determination are
available,44 Kuhnke’s technique is simple, precise, and easily
adaptable to the different shapes of legs.
Conclusions
Our results showed a significant augmentation of the pain
threshold and well-being after 5 andullation sessions of 30 min
each in healthy and unhealthy participants. The values of pain
perception, arterial pressure, and lower limb volume decreased
significantly after the andullation sessions. These results indi-
cate that an andullation device may be a nonrisky instrument
that can be applied as a therapy for pain relief and valuable for
lessening arterial pressure and lower limb volume.
Limitations of the Study and Clinical Applications
Because we included healthy and unhealthy participants with a
wide range of ages in our study, we cannot specify the effects
of andullation therapy on one specific group regarding either
age or mild diseases within the whole range (18–68 years old).
Therefore, the possibility exists that the effects were larger for
unhealthy participants than for healthy one. This remains to be
clarified.
Because we did not use a control group for different reasons,
we cannot extrapolate our results to the general population.
Nevertheless, andullation therapy has shown to be beneficial
for most of the participants in our study, suggesting that it can
be a helpful tool for clinical applications to improve the quality
of life of patients.
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